Grants per year
- 25 - 50 out of 7,255 results
Search results
-
Active
AIDA-AI: Amyloidosis Diagnosis Acceleration with Artificial Intelligence
Ahmad, F. S. (PD/PI) & Shah, S. J. (Co-PD/PI)
AstraZeneca Pharmaceuticals LP
12/5/24 → 12/4/27
Project: Research project
-
Influenza Modeling of Correlates of Protection for Optimal Immune Dynamics and Evolution.
Fourati, S. (PD/PI)
Emory University, National Institute of Allergy and Infectious Diseases
12/1/24 → 11/30/25
Project: Research project
-
Lauren Petrovich IPA
Budinger, G. S. (PD/PI) & Petrovich, L. D. (Other)
12/1/24 → 11/30/25
Project: Research project
-
A mixed-methods study of home care workers’ support for older Asian American adults’ management of type 2 diabetes
Vu, M. (PD/PI) & Kandula, N. R. (Co-Investigator)
12/1/24 → 11/30/25
Project: Research project
-
Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV Infection
Abdel-Mohsen, M. (PD/PI)
National Institute of Allergy and Infectious Diseases
12/1/24 → 5/31/26
Project: Research project
-
-
Prot #M22-003: A Phase 3, Multicenter, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of Epcoritamab + Rituximab and Lenalidomide (R2) Compared to Chemoimmunotherapy in Previously Untreated Follicular Lymphoma (EPCORE™FL-2)
Karmali, R. (PD/PI)
11/22/24 → 11/22/27
Project: Research project
-
Prot #ABX464-105: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects with Moderately to Severely Active Ulcerative Colitis (ABTECT-1)
Hanauer, S. B. (PD/PI)
11/19/24 → 11/19/27
Project: Research project
-
Understanding BCL6 gene regulation, its role in fibrosis, and its impact on liver regeneration
Barish, G. D. (PD/PI)
Boehringer Ingelheim International GmbH
11/19/24 → 11/19/26
Project: Research project
-
Prot #TP-CA-006: TEMPUS PHOENIX HNSCC STUDY: A Longitudinal Multi-Omic Biomarker Profiling Study of Patients with Head & Neck Squamous Cell Carcinoma (HNSCC)
Lorch, J.H.-M. (PD/PI)
11/14/24 → 11/14/27
Project: Research project
-
Prot #TV56278-ONC-10203: A Phase 1a/1b Open-Label, Multicenter, Dose Escalation, and Dose Expansion Trial to Evaluate the Safety and Activity of TEV-56278, as a Monotherapy and in Combination with Pembrolizumab in Participants with Selected Locally Advanc
Chae, Y. K. (PD/PI)
ICON Clinical Research, LLC, Teva Branded Pharmaceutical Products R&D, Inc.
11/13/24 → 11/13/27
Project: Research project
-
Prot #221611: A Phase 3b, Open Label, Randomized, Standard-Of-Care Control Arm, Multicenter, Superiority Study Evaluating the Efficacy, Safety and Tolerability of Injectable CAB LA + RPV LA in Viremic Participants Living with HIV-1 (CROWN)
Jose, J.-A. (PD/PI)
PPD Investigator Services, LLC, GlaxoSmithKline LLC
11/7/24 → 11/7/27
Project: Research project
-
Prot #RVT-2301-201: A Phase 2, Randomized, Placebo-Controlled Trial to Assess the Efficacy and Safety of Mosliciguat in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease
Mylvaganam, R. J. (PD/PI)
Ice Global Consulting, Inc., Pulmovant, Inc.
11/7/24 → 11/7/27
Project: Research project
-
Prot #M24-064: AndroMETa-CRC-064: An Open Label, Randomized, Controlled, Global Phase 3 Study Comparing ABBV-400 Monotherapy to LONSURF (Trifluridine and Tipiracil) plus Bevacizumab in Subjects with c-Met Over-Expressed Refractory Metastatic Colorectal Ca
Benson III, A. B. (PD/PI)
11/6/24 → 11/6/27
Project: Research project
-
Overcoming Resistance in Synovial Sarcoma to Interferon Gamma Mediated Immuno-sensitization
Pollack, S. M. (PD/PI), Chen, R. (Co-Investigator) & Obeidin, F. (Co-Investigator)
U.S. Army Medical Research and Materiel Command
11/1/24 → 10/31/27
Project: Research project
-
Implementing Integrated Services for People With HIV and Opioid Use Disorder
Nyaku, A. N. (PD/PI), Nyaku, A. N. (PD/PI), Scott, K. (Other) & Scott, K. (Other)
National Institute on Drug Abuse
11/1/24 → 3/31/26
Project: Research project
-
Prot #STU00220314: Evaluation of the Boston Scientific WCM Patch as a Non-Invasive Tool for the Diagnosis and Management of Heart Failure: A Pilot Study
Shah, S. J. (PD/PI)
10/28/24 → 10/28/26
Project: Research project
-
Prot #DS7300-189: A Phase 1b/2, Multicenter, Open-Label Study of Ifinatamab Deruxtecan (I-DXd), A B7H3 Antibody-Drug Conjugate (ADC), in Combination with Atezolizumab with or without Carboplatin as First-Line Induction or Maintenance, in Subjects with Ext
Patel, J. D. (PD/PI)
Quintiles, Inc., Daiichi Sankyo, Inc.
10/25/24 → 10/25/27
Project: Research project
-
Prot #ITL-2001-CL-311: MAGNITUDE-2: A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Hereditary Transthyretin Amyloidosis with Polyneuropathy (ATTRv-PN)
Shah, S. J. (PD/PI)
10/24/24 → 10/24/27
Project: Research project
-
Prot #NU 23S02: An Analysis of Nectin‐4 Expression in Soft Tissue Sarcoma
Pollack, S. M. (PD/PI)
Astellas Pharma Global Development, Inc.
10/21/24 → 4/21/26
Project: Research project
-
Prot #R668-AS-2373: AIM4: Next Step – Asthma Uncontrolled with ICS in Medium Dose (GINA 4): Next Step; Efficacy of Dupilumab Added to Medium Dose ICS/LABA in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Patients with Uncontrolled Asthma
Rosenberg, S. R. (PD/PI)
Parexel, Regeneron Pharmaceuticals, Inc.
10/18/24 → 10/18/27
Project: Research project
-
Prot #CNST0610C210: An Open-Label, Multicenter, Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Stein, B. L. (PD/PI)
Novotech Clinical Research USA, LLC, Constellation Pharmaceuticals, Inc.
10/16/24 → 10/16/27
Project: Research project
-
Prot #ACT18018: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of Itepekimab, in Participants with Non-Cystic Fibrosis Bronchiectasis
Sala, M. A. (PD/PI)
ICON Clinical Research, LLC, Sanofi US Services Inc.
10/16/24 → 10/16/27
Project: Research project